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ABSTRACT
Objective: To determine the diagnostic accuracy of DWI in differentiating benign and malignant meningiomas
keeping histopathology as gold standard.
Methods: This was a descriptive analytical study conducted at Radiology Department, DUHS/Dr. Ruth K. M.
Pfau Civil Hospital Karachi, from August 2016 to March 2018.It included152 patients clinically suspected of
meningioma on conventional neuroimaging. Imaging features of DWI were compared with histopathology
findings. The diagnostic accuracy of DWI was calculated in terms of sensitivity, specificity, accuracy, PPV
and NPV using histopathology as gold standard.
Results: There were 59 male and 93 female patients with mean age of 55.38±9.8 years. Mean duration of
sign and symptoms was 5.67±2.57 months. Out of 152 patients, 117(77%) and 35(23%) were differentiated
into benign and malignant meningiomas respectively by DWI while 135(88.82%) and17(11.18%) patients
were diagnosed respectively on histopathology. The sensitivity, specificity, PPV, NPV and accuracy of DWI
of 84.4%, 82.3%, 97.4%, 40%, and 84.2% respectively keeping histopathology as gold standard.
Conclusion: DWI features along with calculation of ADC values is a reliable non-invasive technique for
differentiating benign and malignant meningiomas. However the low negative predictive value necessitates
the use of histopathology.
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Meningiomas are the most common primary
extra-axial non-glial intracranial tumors, comprise
approximately 14–20% of all intracranial tumors.1,2
Meningiomas commonly occur on the brain
surface and rarely in the brain ventricles. Mostly
they are seen in middle aged patients showing
female predilection with male:female ratio of 1:2.3
Tumors less than 2.5cm are rarely symptomatic
whereas, larger tumors show symptoms which
worsen with time.4
Most of meningiomas are typically benign,
slow growing and curable by surgery depending
on location.5 About 10% of meningiomas are
atypical or malignant associated with higher
morbidity and mortality. They may invade the
adjacent bone and brain parenchyma so prone to
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recur in 29% - 41% of patients.6 So it is important
to distinguish them correctly for treatment
planning, deciding the aggressiveness of surgical
resection and the need of combined radiation
therapy.2,7 Though some radiological features on
conventional neuroimaging like intratumoral
cystic change, hyperostosis of the adjacent skull,
bony destruction, extracranial tumor extension
through the skull base, arterial encasement, and
peritumoral brain edema have been found to
distinguish these two entities; no single feature
has been found to be highly reliable.8
Diffusion weighted imaging (DWI) is a noninvasive technique, based on the measurement
of water diffusion in tissues, which provides
information
about
tissue
microstructures,
important in the grading of tumors before surgery.9
Few previous studies have found that the atypical/
malignant meningiomas tend to be markedly
hyperintense on diffusion weighted images
(DWI) and exhibit markedly decreased value on
apparent diffusion coefficient (ADC) imaging when
compared with normal brain parenchyma, while the
benign meningiomas have a variable appearance on
diffusion weighted images and tend to have higher
ADC values compared with normal brain.6,9,10
However these already conflicting results needs to
be validated in our population, where tuberculomas
are common confounders for the meningiomas
and may give a similar appearance with caseous
material simulating signals of calcification on
screening MRI. So this study was conducted to
compare diffusion-weighted imaging findings of
different meningiomas by using apparent diffusion
coefficient (ADC) values for predicting tumor grade
into benign and malignant meningiomas.
METHODS
It was a descriptive analytical study conducted
at CT & MRI Centre, Dow University of Health
Sciences/Dr. Ruth K. M. Pfau Civil Hospital
Karachi, from August 2016 to March 2018. Inclusion
criteria were patients of either gender between 2070 years of age, primarily suspected of meningioma
on clinical features and conventional cross sectional
imaging either on MRI or CT scan in last 12 weeks,
and underwent DWI at the study centre. Patients
who had claustrophobia, history of indwelling
metallic implants and cardiac pacemakers, postoperative or recurrent meningiomas were excluded
from the study.
Sample size was calculated by taking expected
sensitivity 72.9% and specificity 73.1% of DWI9 with
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desired precision of 0.10, 35% prevalence11 and 95%
confidence level. The total calculated sample size
was 152. Written informed consent was obtained
from each subject and permission was also obtained
from The Institutional Review Board.
Diffusion Weighted images (DWI) were obtained
using a single-shot echo planar spin echo technique
(TR/TE/NEX: 4200/140 ms/I) with diffusion
sensitivities of b values = 0, 500 and 1000 s/mm2 on
a 1.5-Tesla MR scanner (GE Health Care Signa H D).
The diffusion gradients were applied sequentially
in three orthogonal directions (X, Y and Z
directions). The scanning parameters were 5 mm
slice thickness, 1mm interslice gap, 240mm FOV
and a matrix of 128 x 256 with 80s total acquisition
time. Three types of images were obtained;
orthogonal images, trace images and ADC maps.
The ADC maps were calculated automatically by
MRI software and included in the sequence. ADC
values were measured in 10− 3mm2/s by keeping
different regions of interest (ROI) in the lesion and
contralateral region.
Images were analyzed and reported as benign
or malignant meningiomas according to DWI
using ADC values and then compared with
histopathological diagnosis obtained later after
tumor resection at the Neurosurgery department of
the same hospital.
Data collected was analyzed by SSPS program
version 20. Mean and standard deviation were
calculated for quantitative variables like age and
duration since diagnosis on conventional MRI/CT
scan.Frequency and percentages were calculated for
qualitative variables like gender, diagnosis on DWI
and histopathological diagnosis were calculated.
The diagnostic accuracy of Diffusion weighted
MRI for differentiating benign and malignant
Meningiomas was calculated in terms of sensitivity,
specificity, positive predictive values and negative
predictive values keeping histopathology as gold
standard. Post-stratification 2x2 table was generated
to calculate these parameters.
RESULTS
One hundred and fifty two patients were enrolled
to determine the diagnostic accuracy of Diffusion
Weighted MRI in differentiating benign and
malignant meningiomas keeping histopathology
as gold standard.There were 59 males and 93
females, aged from 21 to 70 years with mean age
of 55.38 ± 9.8 years. The mean duration of sign and
symptoms of study subjects was 5.67 ± 2.57 months
while the mean duration after primary diagnosis
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Fig.2: Axial T2WI, T1WI, DWI and ADC images reveal
a malignant posterior parietal meningioma showing
diffusion restriction on DWI/ADC and marked
peritumoral edema.

Fig.1: Axial T2WI, T1WI, DWI and ADC images show
a benign suprasellar meningioma without diffusion
restriction on DWI/ADC.

of meningioma on conventional CT / MRI till
differentiation on diffusion weighted MRI of study
subjects was 4.7 ± 2.5 weeks.
Out of 152 patients, 117 patients (77%) showed
benign meningiomas; while 35 patients (23%)
showed malignant meningiomas on diffusion
weighted MRI (DWI) using ADC values (Fig.
1 and 2). While 135 (88.82%) were found to be
benign meningiomas and 17 (11.18%) as malignant
meningiomas on histopathology. Twelve patients
out of 17 having malignant meningioma were seen
in male patients.

So 114 patients were correctly differentiated by
DWI using ADC values as benign meningioma and
14 patients as malignant/atypical meningiomas
when compared with histopathology resulting
in sensitivity of 84.4%, specificity of 82.3%, PPV
of 97.4%, NPV of 40% and accuracy of 84.2%
(Table-I).
DISCUSSION
Meningiomas are common but often an
incidental finding on neuroimaging. The benign
meningiomas are promptly diagnosed but their

Table-I: Diagnostic accuracy of DWI with Histopathology as
Gold Standard to differentiate benign and Malignant Meningiomas (n= 152).
Histopathology
Benign ( n = 135 )

DWI/ADC

P-value

Malignant ( n = 17 )

Total

Benign ( n = 117 )

114

3

117

Malignant ( n = 35 )

21

14

35

TOTAL

135

17

152

Specificity

PPV

NPV

Accuracy

82.3%

97.4%

40%

84.2%

Sensitivity
84.4%

Chi square test was applied, P-Value ≤0.001 considered as significant.
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differentiation from atypical/malignant tumors
by using conventional MRI is still quite difficult.
Neuroimaging
features
like
heterogeneous
signals and enhancement, perilesional edema,
and irregular cerebral surface are not unique and
reliable to diagnose malignant meningiomason
conventional MRI. For the surgical and treatment
planning a diagnostic method is highly desirable for
accurate distinction between benign and malignant
meningiomas.12
Diffusion weighted imaging (DWI) along with the
calculation of apparent diffusion coefficient (ADC),
is a reliable and non-invasive technique of choice
for accurate assessment and in treatment planning
of different types of brain tumors. It has more
advantages in the distinction and differentiation of
benign from malignant meningiomas on the basis
of ADC values.12
Several studies are available that characterize
meningioma by DWI, however the provided data
was inconsistent.6,10,13-15 Some did not identify any
significant difference between the mean ADC ratios
of benign and atypical/malignant tumors13 while
some studies found that the mean ADC value of
benign tumors was significant higher than the ADC
value of atypical/malignant meningiomas.6,10,14,15
So this study was done to assess the overall
performance of the DWI in terms of sensitivity,
specificity, positive predictive value (PPV),
negative predictive value (NPV) and accuracy in
our population.
In this study, the mean age of patients
was 55.38±9.8 years which is comparable to
Kane AJ et al.16 and Ignjatovic J et al.17 that showed
mean age of patients was 54 years and 53 years. In
the current study, meningiomas particularly benign
were found more frequent in females but malignant
meningioma were more commonly observed in
male, which is corroborating the reports from
Samadi N et al.18 and Kane AJ et al.16
The benign meningioma showed variable
appearance like hypointense, isointense and
slightly hyperintense on DWI and ADC maps
with ADC values of more than 0.85×10-3mm2/sec
while malignant/atypical meningiomas returned
hyperintense signals on DWI and hypointense in
ADC maps, with ADC values less than 0.85×103
mm2/sec. Similar signals were demonstrated by
Khedr SA et al.2 and Liu Y et al.19 in their studies.
Liu Y et al.19 also found that hyperintensity of lesion
on DWI as the strongest independent predictor of
high grade meningioma.
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This study showed 84.4% sensitivity of DWI
which was comparable with the study done
by Tantawy HI et al.20 (83.3%) but was higher
than Suruv A et al.15 (72.9%) and less than
Nagar VA et al.14 (96%). The specificity of DWI
was 82.3% in this study which was comparable
to the studies by Nagar VA et al.14 (82.6%)
and Bano S et al.12 (83.2%) but higher than the
study by Todua F et al.21 (80.0%) and Suruv A
et al.15 (73.1%) in differentiating meningiomas.
Our study showed higher positive predictive
value than by Tantawy HI et al.20 (83.3%) and
Nagar VA et al.14 (85.7%).
Our study also showed overall better results
except the negative predictive value than a
study done by Surov A et al.9 who determined
the sensitivity of 72.9%; specificity of 73.1%;
accuracy of 73.0%; positive predictive value of
33.3% and negative predictive value of 96.8%,
respectively taking ADCmean value of less than 0.85
× 10− 3 mm2s− 1 to differentiate between benign and
atypical/malignant meningiomas.
Most previous studies have showed variable
negative predictive value ranging from 68.3%
to 96.8% to distinguish benign and malignant
meningiomas by DWI.9,12,15,20 While our study
showed low negative predictive value of 40%, which
may be either due to different study population,
variation in age and gender of study population
or small sample size of study population. Another
reason may include the necrosis of malignancy that
may be mistaken for cystic change of benign etiology
on DWI alone. So despite good accuracy, sensitivity
and specificity DWI MRI negative for malignancy
still needs to be confirmed with histopathology.
Limitations in this study: It was small sample
size and the study was confined to single centre.
Another limitation was the low negative predictive
value (NPV) in this study likely to be due to varying
tumor morphology, which warrants further
research on larger population.
CONCLUSION
A DWI MRI scan has a high sensitivity, specificity
and accuracy; but a negative scan suggesting benign
disease has to be interpreted with caution due to
low negative predictive value. Histopathology
should not be omitted in such cases.
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